题图来源：123RF
参考资料（可上下滑动查看）
[1] Bornstein, S.R., Wright, J.F. & Steenblock, C. (2024). The promising potential of gene therapy for diabetes mellitus. Nat Rev Endocrinol, DOI: https://doi.org/10.1038/s41574-024-01030-7
[2] Gottlieb, P., Colman, P., Kipnes, M., Ratner, R., Aroda, V., & Rendell, M. (2009, June). Interim results of a Phase I/II clinical trial of a DNA plasmid vaccine (BHT-3021) for Type 1 diabetes. In 69th Annual Meeting of the American Diabetes Association.
[3] Maria Luisa Jaén, et al., (2017). Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs. Mol Ther Methods Clin Dev, DOI: 10.1016/j.omtm.2017.03.008.
[4] Johnson MC, Wang B, Tisch R. (2024). Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes. Hum Vaccin, Doi: 10.4161/hv.7.1.12848.
[5] So WY, Han W.. (2024). Gene therapy targeting key beta cell regulators as a potential intervention for diabetes. EMBO Mol Med, doi: 10.1038/s44321-024-00089-z.
